This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Best-Performing Stocks Under $5 in 2011

Stocks in this article: COOLEEEDYNTADATUSATORSCIGX

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

5. Orsus Xelent Technologies (ORS)

Company Profile: Orsus Xelent is a China-based company that designs and manufactures economically priced cellular phones for retail and wholesale distribution.

Orsus Xelent instituted a 12-for-1 reverse stock split in April to artificially boost its share price from 10 cents to $1.20. By early June, shares rallied sharply higher to a 52-week high of $7.29 in the absence of any company-specific news. The surge was particularly surprising as many other Chinese stocks -- most notably of companies created through reverse mergers -- are flagging due to frequent accounting scandals and intense scrutiny from the Securities and Exchange Commission. Orsus Xelent was formed via reverse merger in March 2005.

Earlier this month, Reuters reported that Orsus Xelent had inaccuracies on its Web site regarding contact info and quoted the company's chief financial officer as being in the dark on why the share price had appreciated so rapidly. "We've gotten calls about the price, but we don't have any idea why the price is so unusual," Orsus Xelent CFO Chen Hua told Reuters. "But I don't pay attention to the trading volume or the stock price."

Current Share Price: $4.87 (June 27)

2011 Total Return: 138%

Analyst Ratings: There are no research firms covering Orsus Xelent currently.

TheStreet Ratings has a "sell" rating on the stock, which it has maintained for more than a year. The latest report highlights Orsus Xelent's "feeble growth in its earnings per share, deteriorating net income, poor profit margins, weak operating cash flow and generally disappointing historical performance in the stock itself."






4. Star Scientific (CIGX)

Company Profile: Star Scientific develops dissolvable smokeless tobacco products, which are billed as delivering fewer carcinogenic toxins.

Shares of Star Scientific began surging in March on reports that compound RCP-006, which the company says is a "nutritional supplement," has potential in treating Alzheimer's. TheStreet's Adam Feuerstein notes that RCP-006, also known as anatabine, "might one day be a cure for Alzheimer's, but it's very premature to make such a claim since this nutritional supplement (not even a drug) has not yet been tested in humans, let alone humans with Alzheimer's."

That skepticism hasn't kept the shares from rising. The stock did take a hit in April before the Food and Drug Administration said it will regulate smokeless electronic cigarettes as it does with traditional tobacco products. Shares are now near their all-time high.

Current Share Price: $4.96 (June 27)

2011 Total Return: 154%

Analyst Ratings: No research analyst follows Star Scientific. TheStreet Ratings does not have a rating on the stock.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

4 of 6

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,810.06 +91.06 0.51%
S&P 500 2,063.50 +10.75 0.52%
NASDAQ 4,712.97 +11.1030 0.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs